This inventor holds 19 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Drug Delivery Systems. Top assignees: Depuy Mitek, Inc., Advanced Technologies and Regenerative Medicine, LLC, Depuy Synthes Products, Inc.. Active years: 2010-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dorchester, MA (US) (2011)
- Franklin, MA (US) (2010 - 2021)
Company Filing History:
6 out of 251 
3 out of 20 
3 out of 2,755 Years Active: 2010-2021
Areas of Expertise:
Title: **Dongling Su: Innovator in Joint Treatment Solutions**
Introduction
Dongling Su, based in Franklin, MA, is a prominent inventor recognized for his significant contributions to medical innovations, particularly in the field of joint treatment. With a remarkable portfolio that includes 19 patents, Su's work focuses on the development of compositions and methods aimed at alleviating joint conditions such as osteoarthritis.
Latest Patents
Among Su's notable patents are two innovative approaches for treating joint conditions. These patents detail compositions that utilize hyaluronic acid (HA) in combination with a lyophilized second component designed to temporarily reduce the viscosity of HA. The second component may include various glycosaminoglycans (GAGs), such as chondroitin sulfate, dermatan sulfate, heparin, and keratan sulfate. The applications of these compositions extend to various synovial joints, including the knee, shoulder, and hip, providing relief from pain and slowing disease progression. Additionally, his inventions encompass the use of glucosamine as an effective supplement in these compositions.
Career Highlights
Throughout his career, Dongling Su has made significant strides in the medical device industry, particularly through his work with internationally recognized companies like DePuy Mitek, Inc. and Advanced Technologies and Regenerative Medicine, LLC. His expertise and innovative mindset have allowed him to impact the field substantially, particularly in developing advanced treatments for joint-related ailments.
Collaborations
Su has collaborated with notable professionals in the industry, including Julia Hwang and Julius Lopez. These partnerships reflect his commitment to pushing the boundaries of medical research and innovation, enabling him to combine diverse expertise to enhance the effectiveness of his patents.
Conclusion
Dongling Su's contributions to joint treatment technologies underscore the vital role of innovation in the medical field. His patents not only signify advancements in the therapeutic management of osteoarthritis but also highlight the importance of collaboration and interdisciplinary approaches in achieving successful outcomes for patients. As he continues to develop more solutions, Su remains a key figure in the quest for improved health and well-being among individuals suffering from joint conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile